Facebook cofounder and philanthropist Sean Parker criticized ClinicalTrials.Gov at an event earlier this month. He made some good points. Here's why we need better ways to help people find clinical trials.
The Facebook cofounder who set up the Parker Institute for Cancer Immunotherapy thinks clinical trial recruitment would benefit from a rating system and would like to inject business acumen into academic scientists.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Old and new research worlds collided on Thursday through the partnership of the decades-old Cancer Research Institute (CRI) and The Parker Institute for Cancer Immunotherapy, created by tech billionaire Sean Parker in April 2016.
Also, an app to reduce child mortality in developing countries, and Merck KGaA loses FDA approval for fertility drug.
Also, Teva talks drug prices; security wonks talk medical device hacks, and ugly talk at the Anthem-Aetna hearings.
Tech entrepreneur Sean Parker just pledged $24 million to Stanford University to set up a new institute for allergy research, and it comes at an important time: We might not be too far, he says, from finding a treatment that’s curative. The new center will be called the Sean N. Parker Center for Allergy Research. It joins a […]
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.